Related Experiment Video
Updated: Feb 21, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Vitamin E in the Preterm Infant: A Forgotten Cause of Hemolytic Anemia
Enrique Gomez-Pomar1, Emily Hatfield2, Karen Garlitz3
1Division of Neonatology, Department of Pediatrics, University of Kentucky, Lexington, Kentucky.
Insights
Some preterm infants still develop hemolytic anemia despite vitamin E supplementation. Those with low hematocrit and high reticulocyte counts may benefit from additional vitamin E therapy.
Area of Science:
- Neonatalogy
- Hematology
- Nutritional Science
Background:
- Vitamin E deficiency is linked to hemolytic anemia in premature infants.
- Supplementation in preterm formulas and parenteral nutrition reduced incidence.
- Some infants still develop hemolytic anemia requiring treatment.
Purpose of the Study:
- To identify factors associated with vitamin E treatment response in preterm infants with hemolytic anemia.
- To determine predictors of adequate response to vitamin E therapy.
Main Methods:
- Retrospective analysis of 70 preterm infants with hemolytic anemia treated with vitamin E.
- Infants classified into responders and non-responders.
- Descriptive statistics and marginal logistic regression used.
Main Results:
- Low hematocrit and high reticulocytosis before treatment predicted adequate response.
- Hematocrit ≤26% and reticulocyte count ≥36.1% were associated with better response.
- Short duration of parenteral nutrition and oxygen use were not associated with response.
Conclusions:
- Preterm infants may develop hemolytic anemia despite standard vitamin E supplementation.
- Additional vitamin E may benefit infants with anemia, reticulocytosis, and oxygen requirements.
Objective:
Vitamin E deficiency in premature infants has been associated with hemolytic anemia. Its incidence decreased after the supplementation of preterm formulas and parenteral nutrition with vitamin E. Despite this, some infants still develop hemolytic anemia and receive vitamin E.
Study Design:
Retrospective analysis of 70 infants admitted to a level IV intensive care unit and who developed hemolytic anemia and were treated with vitamin E. Infants were classified into two groups based on whether or not they responded to vitamin E therapy. Statistical methods included the use of descriptive statistics and marginal logistic regression models.
Results:
Low hematocrit and reticulocytosis before vitamin E administration were associated with adequate response to treatment. Thrombocytosis, iron treatment (duration and dose), gestational age, birth weight, and type of feedings were not. Infants who received a short duration of parenteral nutrition and were on oxygen responded to vitamin E therapy. Infants with a hematocrit ≤ 26% and reticulocyte of 36.1% were more likely to respond to vitamin E.
Conclusion:
Although formulas and parenteral nutrition are supplemented with vitamin E; some preterm infants may still develop hemolytic anemia. Those with anemia, reticulocytosis, and oxygen requirement may benefit from additional vitamin E.
Related Concept Videos
Vitamins
Rh Blood Group
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Teratogenicity

